USSTOCK.TODAY
Market Closed Log in Sign up

Enanta Pharmaceuticals shares decline ahead of September quarterly results

Earnings Whispers · ·by G4L

ENTA
ENTA Enanta Pharmaceuticals Inc
$7.62 -4.51%
View chart & analysis →
  1. 1Enanta Pharmaceuticals shares have fallen 20% since the recent update.
  2. 2The market expects a loss per share of $0.82 for Enanta Pharmaceuticals in the September quarter.
  3. 3Enanta Pharmaceuticals is projected to have revenue of $14.4 million for the September quarter.

So what's the key point?

Enanta Pharmaceuticals shares have recently dropped by 20%. Investors are concerned because losses are expected to be larger than what experts predicted.

Source Earnings Whispers · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →